GAUSS: A Study of Obinutuzumab (RO5072759) in Patients With Indolent Non-Hodgkin's Lymphoma
Clinical trial NCT00576758 · COMPLETED
Trial details
- NCT number
- NCT00576758
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-01-01
- Primary completion
- 2011-09-01
- Enrollment
- 175
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.